SIBN's Quality Score fell 1 point on Tue, Nov 10, to 11. Trading went back to normal after a busy day (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 18% on Nov 3, and still 27% over its Nov 2 close.
“The increase was primarily driven by higher sales commissions on increased revenue”
| The chart | Stronger than 96% of stocks |
| Latest filing | 10-Q, Nov 3 |
After its last 4 reports it closed +8.8% on average, higher 2 of 4 times.
Above Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
SIBN is #24 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 24 |
Expected to report Mon Feb 22, after the close (in 104 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $55.7M, 14% more than a year ago; a loss of $0.08 a share, from $0.11.
“U.S. revenue growth benefited from approximately 19.5% growth in procedure volume partially offset by lower average selling price due to procedure mix and the growing interventional spine physician demand for the INTRA platform in the office-based and ASC sites of care.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| United States | $52.8M | $53.2M | $46.4M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 3)
No outlook figures read from this release.
“Gross margin was 79.3% for the third quarter 2026, compared to 79.8% in the corresponding period in 2025 driven by procedure and site of care mix.”
From its results filing (SEC filing · Nov 2)
Sales grew 22% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 8.1% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 2, 2026 | -3.6% | +17.6% | +26.6% |
| Aug 3, 2026 | -4.0% | -0.1% | +2.1% |
| May 11, 2026 | +8.8% | +19.7% | +27.1% |
Sales grew every year from 2019 to 2025, to $201M. It lost money in each of the seven years.
RSI 67.7, MACD above signal, above both averages. Not scored.
5 insiders sold $1.8M across 31 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: SIBN is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
“We believe that some of our primary competitors include Alphatec Holding Inc., Aurora Spine Corporation, Globus Medical, Inc., Medtronic plc., and Tenon Medical, Inc. amongst others.”
SIBN scores 11 today, which Breakaway calls Above Average. It is #24 of 84 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 18% on Nov 3, and still 27% over its Nov 2 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SIBN scores 11 today, which Breakaway calls Above Average (11 to 14). That is #24 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SIBN's 11.
5 insiders sold $1.8M across 31 filings in the last 6 months. No open-market buys on record. The newest is Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr, who sold $33K on Oct 2. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.